Journal of Clinical Investigation,
Journal Year:
2023,
Volume and Issue:
133(21)
Published: Sept. 18, 2023
The
facilitative
GLUT1
and
GLUT3
hexose
transporters
are
expressed
abundantly
in
macrophages,
but
whether
they
have
distinct
functions
remains
unclear.
We
confirmed
that
expression
increased
after
M1
polarization
stimuli
found
M2
stimulation
macrophages.
Conditional
deletion
of
Glut3
(LysM-Cre
Glut3fl/fl)
impaired
bone
marrow-derived
Alternatively
activated
macrophages
from
the
skin
patients
with
atopic
dermatitis
showed
expression,
a
calcipotriol-induced
model
was
rescued
LysM-Cre
Glut3fl/fl
mice.
M2-like
human
wound
tissues
as
assessed
by
transcriptomics
costaining,
significantly
decreased
nonhealing,
compared
healing,
diabetic
foot
ulcers.
In
an
excisional
healing
model,
mice
macrophage
delayed
healing.
promoted
IL-4/STAT6
signaling,
independently
its
glucose
transport
activity.
Unlike
plasma
membrane-localized
GLUT1,
localized
primarily
to
endosomes
required
for
efficient
endocytosis
IL-4Rα
subunits.
interacted
directly
GTP-bound
RAS
vitro
vivo
through
intracytoplasmic
loop
domain,
this
interaction
STAT6
activation
polarization.
PAK
macropinocytosis
were
also
without
GLUT3,
suggesting
broader
roles
regulation
endocytosis.
Thus,
is
alternative
function,
transport-independent,
RAS-mediated
role
activation.
Cancer Communications,
Journal Year:
2023,
Volume and Issue:
43(5), P. 525 - 561
Published: April 2, 2023
Abstract
Tumor
development
and
metastasis
are
facilitated
by
the
complex
interactions
between
cancer
cells
their
microenvironment,
which
comprises
stromal
extracellular
matrix
(ECM)
components,
among
other
factors.
Stromal
can
adopt
new
phenotypes
to
promote
tumor
cell
invasion.
A
deep
understanding
of
signaling
pathways
involved
in
cell‐to‐cell
cell‐to‐ECM
is
needed
design
effective
intervention
strategies
that
might
interrupt
these
interactions.
In
this
review,
we
describe
microenvironment
(TME)
components
associated
therapeutics.
We
discuss
clinical
advances
prevalent
newly
discovered
TME,
immune
checkpoints
immunosuppressive
chemokines,
currently
used
inhibitors
targeting
pathways.
These
include
both
intrinsic
non‐autonomous
TME:
protein
kinase
C
(PKC)
signaling,
Notch,
transforming
growth
factor
(TGF‐β)
Endoplasmic
Reticulum
(ER)
stress
response,
lactate
Metabolic
reprogramming,
cyclic
GMP–AMP
synthase
(cGAS)–stimulator
interferon
genes
(STING)
Siglec
also
recent
Programmed
Cell
Death
Protein
1
(PD‐1),
Cytotoxic
T‐Lymphocyte
Associated
4
(CTLA4),
T‐cell
immunoglobulin
mucin‐3
(TIM‐3)
Lymphocyte
Activating
Gene
3
(LAG3)
checkpoint
along
with
C‐C
chemokine
receptor
(CCR4)‐
class
chemokines
22
(CCL22)/
17
(CCL17),
type
2
(CCR2)‐
(C‐C
motif)
ligand
(CCL2),
5
(CCR5)‐
(CCL3)
axis
TME.
addition,
review
provides
a
holistic
TME
as
three‐dimensional
microfluidic
models
believed
recapitulate
original
characteristics
patient
hence
may
be
platform
study
mechanisms
screen
for
various
anti‐cancer
therapies.
further
systemic
influences
gut
microbiota
reprogramming
treatment
response.
Overall,
comprehensive
analysis
diverse
most
critical
highlighting
newest
preclinical
studies
underlying
biology.
highlight
importance
technologies
microfluidics
lab‐on‐chip
research
present
an
overview
extrinsic
factors,
such
inhabitant
human
microbiome,
have
potential
modulate
biology
drug
responses.
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: May 6, 2024
Abstract
Background
Metabolic
reprogramming
and
epigenetic
alterations
contribute
to
the
aggressiveness
of
pancreatic
ductal
adenocarcinoma
(PDAC).
Lactate-dependent
histone
modification
is
a
new
type
mark,
which
links
glycolysis
metabolite
process
lactylation.
However,
role
lactylation
in
PDAC
remains
unclear.
Methods
The
level
was
identified
by
western
blot
immunohistochemistry,
its
relationship
with
overall
survival
evaluated
using
Kaplan-Meier
plot.
participation
growth
progression
confirmed
through
inhibition
inhibitors
or
lactate
dehydrogenase
A
(
LDHA
)
knockdown
both
vitro
vivo.
potential
writers
erasers
were
functional
experiments.
target
genes
H3K18
(H3K18la)
screened
CUT&Tag
RNA-seq
analyses.
candidate
TTK
protein
kinase
BUB1
mitotic
checkpoint
serine/threonine
B
BUB1B
validated
ChIP-qPCR,
RT-qPCR
Next,
effects
these
two
overexpression.
interaction
between
Co-IP
assay.
Results
Histone
lactylation,
especially
H3K18la
elevated
PDAC,
high
associated
poor
prognosis.
suppression
glycolytic
activity
different
kinds
contributed
anti-tumor
E1A
binding
p300
(P300)
deacetylase
2
writer
eraser
cells,
respectively.
enriched
at
promoters
activated
transcription
regulators
.
Interestingly,
could
elevate
expression
P300
turn
increased
glycolysis.
Moreover,
phosphorylated
tyrosine
239
(Y239)
LDHA,
subsequently
upregulated
levels.
Conclusions
glycolysis-H3K18la-TTK/BUB1B
positive
feedback
loop
exacerbates
dysfunction
PDAC.
These
findings
delivered
exploration
significant
inter-relationship
metabolic
regulation,
might
pave
way
toward
novel
treatment
strategies
therapy.
Cancer Research,
Journal Year:
2022,
Volume and Issue:
82(19), P. 3516 - 3531
Published: Oct. 4, 2022
Emerging
evidence
demonstrates
that
the
dysregulated
metabolic
enzymes
can
accelerate
tumorigenesis
and
progression
via
both
nonmetabolic
functions.
Further
elucidation
of
role
in
EGFR
inhibitor
resistance
metastasis,
two
leading
causes
death
lung
adenocarcinoma,
could
help
improve
patient
outcomes.
Here,
we
found
aberrant
upregulation
phosphoserine
aminotransferase
1
(PSAT1)
confers
erlotinib
tumor
metastasis
adenocarcinoma.
Depletion
PSAT1
restored
sensitivity
to
synergistically
augmented
tumoricidal
effect.
Mechanistically,
inhibition
activated
ROS-dependent
JNK/c-Jun
pathway
induce
cell
apoptosis.
In
addition,
interacted
with
IQGAP1,
subsequently
activating
STAT3-mediated
migration
independent
its
activity.
Clinical
analyses
showed
expression
positively
correlated
human
Collectively,
these
findings
reveal
multifunctionality
promoting
malignancy
through
activities.Metabolic
functions
confer
promote
suggesting
therapeutic
targeting
may
attenuate
malignant
features
cancer.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2023,
Volume and Issue:
42(1)
Published: March 22, 2023
Metastases
are
the
major
cause
of
cancer-related
morbidity
and
mortality.
By
time
cancer
cells
detach
from
their
primary
site
to
eventually
spread
distant
sites,
they
need
acquire
ability
survive
in
non-adherent
conditions
proliferate
within
a
new
microenvironment
spite
stressing
that
may
severely
constrain
metastatic
process.
In
this
study,
we
gained
insight
into
molecular
mechanisms
allowing
an
anchorage-independent
manner,
regardless
both
tumor-intrinsic
variables
nutrient
culture
conditions.3D
spheroids
derived
lung
adenocarcinoma
(LUAD)
breast
were
cultured
either
nutrient-rich
or
-restricted
conditions.
A
multi-omics
approach,
including
transcriptomics,
proteomics,
metabolomics,
was
used
explore
changes
underlying
transition
2
3D
cultures.
Small
interfering
RNA-mediated
loss
function
assays
validate
role
identified
differentially
expressed
genes
proteins
H460
HCC827
LUAD
as
well
MCF7
T47D
cell
lines.We
found
cultures
is
associated
with
significant
expression
involved
metabolic
reprogramming.
particular,
observed
tumor
spheroid
growth
implies
overexpression
ALDOC
ENO2
glycolytic
enzymes
concomitant
enhanced
consumption
glucose
fructose
production
lactate.
Transfection
siRNA
against
determined
reduction
lactate
production,
viability
size
produced
by
H460,
HCC827,
MCF7,
lines.Our
results
show
survival
supported
drive
metabolism
towards
production.
Notably,
finding
valid
for
all
lines
have
analyzed
different
environmental
broader
Validation
mechanism
other
origin
will
be
necessary
broaden
types.
Future
vivo
studies
assess
metastasis.